Stockreport

Zevra Therapeutics Reports First Quarter 2024 Financial Results and Corporate Updates [Yahoo! Finance]

Zevra Therapeutics, Inc.  (ZVRA) 
PDF Arimoclomol NDA review underway with PDUFA date of September 21, 2024 Reported positive topline results from KP1077 Phase 2 Trial in idiopathic hypersomnia , with ful [Read more]